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Early studies from the Coronary Drug Project of sudden cardiac death 
in patients surviving an episode of myocardial infarction called attention to the 
importance of ventricular ectopic beats.' In that study, complex ventricular 
ectopic beats recorded on a 12-hour Holter electrocardiogram were found 
to be associated with an excessive risk of sudden cardiac death. When the rela- 
tionship was examined between complex ventricular ectopic beats and other risk 
factors, such as age, number of prior infarctions, angina pectoris, hypertension, 
serum cholesterol, glucose intolerance, cardiomegaly seen on chest X-ray 
films, and cigarette-smoking, complex ventricular ectopic beats were found to be 
independent risk factors with respect to sudden cardiac death. The importance 
of ventricular ectopic beats as a predictor of sudden cardiac death during the 
convalescent or late hospital phase of acute myocardial infarction in this and 
other studies has led to the use of prophylactic antiarrhythmic therapy in an  
attempt to prevent or reduce these ectopic beats and hence to prevent sudden 
cardiac death. 
In a subsequent study by Schulze et al. patients surviving an episode of acute 
myocardial infarction underwent 24-hour Holter electrocardiographic recording 
and gated radionuclide left ventricular angiography prior to discharge from the 
hospital.? Several important findings emerged from this study: It  was noted 
that 26 of 29 (90%) patients with complex ventricular arrhythmias (Lown 
Class 111-V) on Holter electrocardiographic recording had a left ventricular 
ejection fraction of <40% compared with only 19 of 52 (37%) without 
complex ventricular arrhythmias. During a mean follow-up period of 7 months, 
eight patients had documented ventricular fibrillation. All eight patients who 
suffered sudden death were in the subset of patients with complex late hospital 
phase ventricular arrhythmias and a left ventricular ejection fraction of <40%. 
This study was one of the first to call attention to the role of ventricular dysfunc- 
tion in patients with sudden cardiac death after an episode of acute myocardial 
infarction. The failure of left ventricular dysfunction to be recognized as an 
important predictor of sudden death after myocardial infarction in the Coronary 
Drug Project and in other previous studies may be related to the use of the 
cardiothoracic (CT) ratio on chest X-ray film as an index of left ventricular 
function. Subsequent studies have pointed out that the CT ratio is a poor index 
of left ventricular function and that the correlation between the CT ratio and 
left ventricular ejection fraction is poor. Schulze et al. also found that the left 
ventricular ejection fraction and the percent of left ventricular akinesia on gated 
blood pool imaging were significantly better predictors of subsequent sudden 
cardiac death than was peak creatine phosphokinase (CPK) determined during 
the episode of acute infarction. Patients who subsequently died suddenly had 
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a higher peak CPK than those who survived, but this difference was not signifi- 
cant. In contrast, those who died suddenly had a significantly lower left ven- 
tricular ejection fraction and a greater percentage of left ventricular akinesia 
than those who survived. The failure of peak CPK to adequately predict those 
at risk for subsequent sudden death is due to the fact that it is the total myo- 
cardial damage that appears to be of importance rather than just the acute 
damage, which is reflected by the rise in CPK. Left ventricular ejection fraction 
and the percent of left ventricular akinesia reflect total myocardial damage due 
to previous infarction as well as acute infarction and therefore appear to be 
better predictors. 
The importance of ventricular dysfunction as a predictor of subsequent 
sudden cardiac death after myocardial infarction can also be seen in a study by 
Ruberman et al.3 In that study of 1739 patients with prior myocardial in- 
farction who underwent a 1 -hour electrocardiographic recording and were 
followed for a mean of 24.4 months, complex ventricular ectopic beats were 
again found to be an important predictor of subsequent sudden and nonsudden 
cardiac death. However, the combination of complex ventricular ectopic 
activity on the I-hour electrocardiographic recording and a history of congestive 
heart failure showed the highest relative risk for subsequent death, both sudden 
and non~udden.~  
In subsequent studies by Schulze et al. it was noted that patients with 
complex late hospital phase ventricular ectopic beats on 24-hour Holter elec- 
trocardiographic recording prior to discharge from the hospital after an episode 
of acute myocardial infarction had a significantly greater incidence of multi- 
vessel coronary artery disease than did those without complex ventricular 
arrhythmias, as well as a significantly greater incidence of abnormally con- 
tracting myocardial segments and a lower left ventricular ejection fraction on 
contrast left ventri~ulography.~ The more extensive coronary artery disease 
and left ventricular dysfunction and hence increased risk of myocardial ischemia 
in patients with complex ventricular arrhythmias after myocardial infarction 
were thought to help explain the relative refractoriness of many of the ar- 
rhythmias in these patients to standard antiarrhythmic therapy. 
In  a study of 106 patients surviving an episode of acute myocardial in- 
farction who underwent 24-hour Holter electrocardiographic recording and 
coronary angiography prior to hospital dischage, Taylor et al., using univariate 
analysis, also noted that a low left ventricular ejection fraction, proximal left 
anterior descending coronary artery disease, and significant triple-vessel disease 
were associated with a high risk of subsequent sudden cardiac death.5 Multi- 
variate analysis of 30 clinical and laboratory values identified previous myocar- 
dial infarction and a left ventricular ejection fraction of <40% as the best pre- 
dictor of mortality. In this analysis the presence of complex late hospital phase 
ventricular arrhythmias did not provide additional prognostic information as to 
subsequent sudden death once the information as to previous infarction and 
ejection fraction was considered. In  a recent study in which 10-hour Holter 
electrocardiographic recordings were made on 289 survivors of an episode of 
acute myocardial infarction Klieger et al. also found that the occurrence of 
ventricular runs on electrocardiographic recording was related to left ventricular 
dysfunction.6 However, analysis of the data led the authors to conclude that the 
presence of ventricular runs on electrocardiographic recording was a marker 
of severe cardiac disease rather than an independent risk factor for predicting 
subsequent sudden cardiac death. 
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On the basis of these and other studies, it appears that complex ventricular 
arrhythmias and left ventricular dysfunction are important predictors of death 
after myocardial infarction, both sudden and nonsudden. The complex ven- 
tricular arrhythmias seen during the late hospital phase of acute myocardial 
infarction, however, may be “innocent bystanders” and merely markers of left 
ventricular dysfunction rather than independent risk factors for subsequent 
sudden cardiac death. Indirect support for this hypothesis can be found from 
an analysis of several recent therapeutic trials. Attempts to reduce sudden 
cardiac death by prophylactic antiarrhythmic therapy or by suppressing complex 
ventricular ectopic activity after myocardial infarction have not been successful. 
For example, in a recent study of mexiletine in the postinfarction period it was 
found that complex ventricular ectopic beats could be successfully s~ppressed .~  
Nevertheless, the incidence of sudden cardiac death was not reduced. In fact, 
there was a slightly higher incidence of death in those receiving mexiletine. 
Previous and ongoing trials of antiarrhythmic agents given to prevent sudden 
cardiac death after myocardial infarction have also failed, and although one 
could argue that such failure to reduce the incidence of sudden cardiac death 
after myocardial infarction may be due to the inadequacies of either the trial 
design or of currently available antiarrhythmic agents, it could equally be 
argued that the concept of prophylactic or suppressive antiarrhythmic therapy to 
prevent sudden death is inadequate and that new approaches to this problem are 
needed. Further support for the hypothesis that complex ventricular arrhythmias 
after myocardial infarction are merely incidental and not critical to the subse- 
quent development of sudden cardiac death comes from the recent Norwegian 
trial of timolol in patients recovering from an episode of acute myocardial 
infarction.8 In this study timolol was shown to significantly reduce the incidence 
of both sudden and nonsudden death after infarction. However, the reduction in 
incidence of sudden cardiac death by timolol was not reported to be associated 
with any significant reduction in complex ventricular ectopic activity. 
If complex ventricular ectopic beats during the late hospital phase of acute 
myocardial infarction are merely “innocent bystanders” and markers of ven- 
tricular dysfunction and/ or extensive ischemic heart disease rather than primary 
etiologic factors for subsequent sudden death, how can we explain the impor- 
tance of ventricular dysfunction as a risk factor and what is its implication for 
the prevention of subsequent sudden cardiac death after infarction? Our 
current hypothesis, based upon our previous experience 2, 4. and that of others, 
is that extensive myocardial damage makes the ventricle vulnerable to what 
might otherwise be subthreshold stimuli. These stimuli may cause hetero- 
geneous repolarization and electrical disorganization, resulting in ventricular 
fibrillation and sudden death. For example, a patient with extensive myocardial 
damage and multivessel coronary artery disease may develop ventricular 
fibrillation after administration of relatively small concentrations of catechol- 
amines. Similar catecholamine concentrations in a patient wtih a normal ven- 
tricle without coronary artery disease would not cause ventricular fibrillation or 
sudden cardiac death. Thus, timolol could have prevented sudden cardiac death 
by blocking the effects of catecholamines in patients with extensive myocardial 
damage or coronary arterial narowing, or both. Other subthreshold humoral or 
neural humoral factors or both may also be of impotance and precipitate 
ventricular fibrillation in patients with extensive myocardial dysfunction. Recent 
studies in our laboratory suggest that intracerebral opiate administration can 
cause profound systemic and coronary vasoconstriction,9 and in the presence of 
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extensive myocardial damage, it is possible that intracerebral endogenous opioid 
release could result in myocardial ischemia, ventricular fibrillation, and sudden 
cardiac death. 
In the foregoing discussion it has been emphasized that left ventricular 
dysfunction and extensive coronary artery disease are important factors in the 
occurrence of sudden cardiac death. This, of course, is true only for those with 
ischemic heart disease. A relatively large percentage of patients who die 
suddenly do  not have ischemic heart disease or ventricular dysfunction. Sudden 
cardiac death in these patients without known cardiac disease may be due to 
threshold rather than subthreshold stimuli. For example, a release of high 
concentrations of catecholamines and/or other neural or humoral factors may be 
required to cause inhomogeneity in ventricular conduction and to precipitate 
sudden death in the normal ventricle. The incidence of sudden death in those 
without myocardial damage and ischemic heart disease is relatively low since it 
is relatively uncommon that these neural or humoral factors reach threshold 
levels. On the other hand, in the patient with extensive myocardial dysfunction 
and ischemic heart disease, catecholamine levels in the coronary sinus are 
relatively high. The presence of left ventricular dysfunction and an increased 
vulnerability to ventricular fibrillation may in conjunction with other neural o r  
humoral factors lead to sudden death. If this hypothesis is correct, the approach 
to the prophylaxis of sudden cardiac death will depend upon a better under- 
standing of the neural and humoral stimuli, both subthreshold and threshold, 
which result in ventricular fibrillation. If these stimuli can be identified and the 
factors that control their release and mechanisms of action understood, it is 
possible that appropriate prophylactic strategies for the prevention of sudden 
cardiac death could be developed. Development of new antiarrhythmic agents, 
the use of extensive Holter electrocardiographic recording, and the application 
of electrophysiologic techniques may be of benefit to the patient with sympto- 
matic ventricular tachycardia and/ or recurrent ventricular fibrillation, but these 
techniques have not and probably will not be of benefit in developing an 
effective prophylactic approach to the overall problem of sudden cardiac death 
or to the particular subset of patients surviving an episode of acute myocardial 
infarction with extensive left ventricular dysfunction. 
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DISCUSSION 
R. BAIGRIE (Toronto, Ontario, Canada) : Dr. Pitt could you tell me what 
percentage of sudden deaths in North America each year are postinfarction 
sudden deaths? 
DR. PITT: Perhaps Dr. Cobb would be better prepared to answer that. 
DR. COBB: It is difficult to answer with certainty, but this question is very 
important. Of the patients that we see after resuscitation from out-of-hospital 
ventricular fibrillation due to coronary disease, 60% have no history of prior 
myocardial infarction, and 40% do. About 15% of the patients appear to have 
had a myocardial infarction within the preceding 6 months to a year. So while 
they do not represent an enormous part of the sudden death population, this 
subset is obviously very important. 
DR. P. GALLERSTEIN (New York, New York) : We have noticed that in a 
lot of the patients coming to our coronary care unit with very poor left ven- 
tricular function and complex arrhythmias, the arrhythmias have actually 
subsided as we have sought to improve left ventricular function by the very 
aggressive use of both pre- and afterload agents. Have you looked at this? 
DR. PITT: We haven’t examined this directly, but the few data that I am 
familiar with seem to indicate that although ventricular function can be altered 
by afterload-reducing agents, the overall mortality has not changed. Perhaps 
these premature ventricular contractions are really markers, hut not necessarily 
the event that triggers death. 
DR. HERLING: You appropriately negate the role of empirical antiarrhythmic 
therapy in preventing sudden death in the high-risk subgroup, but how do 
you regard the role of programmed electrical stimulation in the electrophysiology 
laboratory to identify those high-risk subsets who may sustain recurrent ven- 
tricular tachycardia? 
DR. PITT: This will be discussed later by others. 
